Fluconazole Renal Dose Adjustment
For patients with impaired renal function requiring multiple doses of fluconazole, administer a full loading dose (50-400 mg based on indication), then reduce the maintenance dose to 50% of the standard daily dose if creatinine clearance is ≤50 mL/min (without dialysis), or give 100% of the recommended dose after each hemodialysis session. 1
Dosing Algorithm by Renal Function
Step 1: Determine Creatinine Clearance
- Calculate CrCl using the Cockcroft-Gault equation 1:
- Males: [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]
- Females: 0.85 × male value
- Pediatric patients: [K × height (cm)] / serum creatinine (mg/dL), where K = 0.55 for children >1 year and 0.45 for infants 1
Step 2: Apply Renal Dosing Strategy
Loading Dose (Day 1):
- Give full loading dose (50-400 mg based on indication) regardless of renal function 1
- This ensures rapid achievement of therapeutic concentrations 1
Maintenance Dosing (Day 2 onwards):
| Creatinine Clearance | Recommended Dose |
|---|---|
| >50 mL/min | 100% of standard dose [1] |
| ≤50 mL/min (no dialysis) | 50% of standard dose [1] |
| Hemodialysis | 100% after each dialysis session [1] |
Critical Considerations for Specific Populations
Hemodialysis Patients
- Administer 100% of the recommended dose after each hemodialysis session 1
- On non-dialysis days, use the reduced dose according to creatinine clearance 1
- Approximately 38-50% of fluconazole is removed during a 3-hour hemodialysis session 2, 1
Critically Ill Patients on CRRT
- Higher doses are required: Recent evidence demonstrates that critically ill patients on Continuous Veno-Venous Hemodialysis (CVVHD) need at least 400 mg twice daily to achieve target attainment 3
- Standard renal dosing recommendations may be insufficient in this population due to increased clearance through CRRT 3
- For ICU patients on CRRT, consider 800 mg daily to achieve EUCAST-recommended pharmacodynamic targets 4
Pediatric Renal Impairment
- Dosage reduction should parallel adult recommendations 1
- Although pharmacokinetic studies in children with renal insufficiency are limited, the same proportional dose adjustments apply 1
Pharmacokinetic Rationale
Why dose adjustment is necessary:
- Fluconazole is cleared primarily by renal excretion as unchanged drug (approximately 80% of dose) 1
- Renal impairment significantly affects fluconazole pharmacokinetics 5, 2:
Important Caveats
Single-Dose Therapy Exception
- No dose adjustment needed for single-dose therapy (e.g., vaginal candidiasis with 150 mg single dose) 1
Monitoring Considerations
- Further adjustment may be needed based on clinical condition beyond the standard pharmacokinetic-based recommendations 1
- Trough concentrations correlate well with AUC, making therapeutic drug monitoring feasible for dose optimization 4
Elderly Patients
- Higher pharmacokinetic parameter values in elderly patients are primarily due to age-related decline in renal function rather than age itself 1
- Apply standard renal dosing adjustments based on calculated creatinine clearance 1
Drug Interactions
- Fluconazole has low protein binding (11-12%), minimizing displacement interactions 1
- Unlike ketoconazole, fluconazole has minimal effects on steroidogenesis at therapeutic doses 6
Continuous Ambulatory Peritoneal Dialysis (CAPD)
- For fungal peritonitis in CAPD patients: 50 mg intraperitoneally or 100 mg orally 7
Standard Indication-Based Dosing (Before Renal Adjustment)
For reference, standard doses by indication include 8:
- Oropharyngeal candidiasis: 200 mg daily
- Esophageal candidiasis: 200-400 mg daily
- Candidemia/invasive candidiasis: 400-800 mg daily (6-12 mg/kg)
- Cryptococcal meningitis: 400 mg daily (6 mg/kg)
- Urinary tract candidiasis: 200-400 mg daily
Apply the renal dosing algorithm above to these standard doses when CrCl ≤50 mL/min 1.